Pacific Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Pacific Capital Partners's LLY Position: Q3 2026 in Review
Pacific Capital Partners reduced its Eli Lilly (LLY) stake by 14% in Q3 2026, selling an estimated $372K and leaving 1,942 shares worth $2.25M. The position accounts for 1.7% of the portfolio, ranked #23.
Pacific Capital Partners first reported a position in LLY in Q3 2023 and has held it in 9 quarters since. The position peaked at $2.71M in Q2 2026. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Pacific Capital Partners held 1,942 shares of Eli Lilly worth $2.25M as of Q3 2026.
- Pacific Capital Partners sold 315 Eli Lilly shares in Q3 2026, an estimated $372K.
- Eli Lilly made up 1.7% of Pacific Capital Partners's portfolio in Q3 2026, its #23 holding.
- Pacific Capital Partners first reported a position in Eli Lilly in Q3 2023 and has held it in 9 quarters since.
- Pacific Capital Partners's Eli Lilly position peaked at $2.71M in Q2 2026.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Pacific Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.